Intra‐Annular Versus Supra‐Annular Self‐Expanding Valves for Valve‐in‐Valve TAVR
VIV TAVR using an IA SEV was safe in this case series with no difference in hemodynamics between IA SEV and SA SEV. These findings provide support for prospective evaluations of an IA SEV for VIV TAVR.
Authors
- Kern Ja
- Leora T. Yarboro (ORCID: https://orcid.org/0000-0003-2104-4961)
- Philip Lavenburg
- Adanna Akujuo
- Kenan W Yount
- Jeffrey Chidester (ORCID: https://orcid.org/0000-0001-5191-1179)
- John Saxon (ORCID: https://orcid.org/0000-0001-9478-9273)
- Keith Allen
- C Toma
- Dustin Kliner
- Adnan K. Chhatriwalla
- Amber Makani
- Alex Wisniewski
- Ibrahim Sultan
- Derek Serna‐Gallegos
- Jared Beller
- Michael Ragosta
- David West
- Pradeep Yadav
- Rishi Puri
Institutions
- Cleveland Clinic (US)
- Valve (United States) (US)
- University of Virginia Health System (US)
- University of Pittsburgh Medical Center (US)
- Saint Luke's Hospital (US)
- University of Virginia (US)
Publication Details
- Journal
- Catheterization and Cardiovascular Interventions
- Published
- 2026-02-09
- DOI
- https://doi.org/10.1002/ccd.70507
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00